3 ms·
While big pharma does do internal r&d, de facto, new drugs and drug strategies largely come by letting the government fund researchers (typically professors at
by dnautics 8y ago
While big pharma does do internal r&d, de facto, new drugs and drug strategies largely come by letting the government fund researchers (typically professors at large research institutes), encouraging these professors to do a spin-off (I deliberately don't want to use "startup") to absorb the scientific risk, followed by an acquisition for IP.